Literature DB >> 6271811

Receptor-mediated regulation of superoxide production in human neutrophils stimulated by phorbol myristate acetate.

R I Lehrer, L Cohen.   

Abstract

Human neutrophils contain receptors for phorbol myristate acetate (PMA), a complex lipid that induces them to generate superoxide (O (2)). Binding of PMA to these receptors displays specificity, reversibility, and high affinity. The receptor's apparent KD was approximately 0.29 nM and multiple copies (approximately 2.1 +/- 0.6 x 10(5)) were present per neutrophil. We found that the timing and magnitude of the neutrophil's respiratory burst were set independently. The onset of O (2) production occurred after a lag that was inversely proportional to the initial concentration of added PMA. The extent (rate) of O (2) production was directly proportional to the fractional occupancy of the receptor by PMA. Dual regulatory controls, such as those we noted when neutrophils were stimulated by PMA, could afford metabolic stability in the face of transient or low intensity stimuli without compromising quick and powerful responses to larger disturbances.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6271811      PMCID: PMC370927          DOI: 10.1172/jci110378

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

1.  Spectrum of horse-heart cytochrome c.

Authors:  E MARGOLIASH; N FROHWIRT
Journal:  Biochem J       Date:  1959-03       Impact factor: 3.857

2.  Activity and activation of the granulocyte superoxide-generating system.

Authors:  P E Newburger; M E Chovaniec; H J Cohen
Journal:  Blood       Date:  1980-01       Impact factor: 22.113

3.  Superoxide generation by digitonin-stimulated guinea pig granulocytes. A basis for a continuous assay for monitoring superoxide production and for the study of the activation of the generating system.

Authors:  H J Cohen; M E Chovaniec
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

Review 4.  Phorbolesters--the irritants and cocarcinogens of Croton Tiglium L.

Authors:  E Hecker; R Schmidt
Journal:  Fortschr Chem Org Naturst       Date:  1974

5.  Induction of differentiation in human promyelocytic leukemia cells by tumor promoters.

Authors:  G Rovera; T G O'Brien; L Diamond
Journal:  Science       Date:  1979-05-25       Impact factor: 47.728

6.  Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents.

Authors:  E Huberman; M F Callaham
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

7.  Effect of phorbol myristate acetate on the oxidative metabolism of human polymorphonuclear leukocytes.

Authors:  L R DeChatelet; P S Shirley; R B Johnston
Journal:  Blood       Date:  1976-04       Impact factor: 22.113

8.  Enhancing effect of phorbol esters on induction of differentiation of mouse myeloid leukemia cells by human urinary protein and lipopolysaccharide.

Authors:  M Nakayasu; M Shoji; N Aoki; S Sato; M Miwa; T Sugimura
Journal:  Cancer Res       Date:  1979-11       Impact factor: 12.701

9.  Specific binding of phorbol ester tumor promoters.

Authors:  P E Driedger; P M Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

10.  Effects of phorbol myristate acetate on the metabolism and ultrastructure of neutrophils in chronic granulomatous disease.

Authors:  J E Repine; J G White; C C Clawson; B M Holmes
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

View more
  26 in total

1.  Adhesion of polymorphonuclear leukocytes to endothelium enhances the efficiency of detoxification of oxygen-free radicals.

Authors:  R L Hoover; J M Robinson; M J Karnovsky
Journal:  Am J Pathol       Date:  1987-02       Impact factor: 4.307

2.  Alterations in complement-induced shape change and stimulus-specific superoxide anion generation by neonatal calf neutrophils.

Authors:  W Holden; D O Slauson; R D Zwahlen; M M Suyemoto; M Doré; N R Neilsen
Journal:  Inflammation       Date:  1989-12       Impact factor: 4.092

3.  Induction of Epstein-Barr virus early antigens by tumor promoters of the diterpene ester type in Raji cells and specific (receptor) binding as compared to irritant and promoting activities.

Authors:  U Kloz; M Hergenhahn; M Fellhauer; E Hecker
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

4.  Inhibition of ciliary activity by phorbol esters in rabbit tracheal epithelial cells.

Authors:  K Kobayashi; J Tamaoki; N Sakai; A Chiyotani; T Takizawa
Journal:  Lung       Date:  1989       Impact factor: 2.584

5.  Ceruloplasmin reduces the adhesion and scavenges superoxide during the interaction of activated polymorphonuclear leukocytes with endothelial cells.

Authors:  C Broadley; R L Hoover
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

6.  Human polymorphonuclear leukocyte-mediated cytotoxicity against varicella-zoster virus-infected fibroblasts.

Authors:  T Ihara; S E Starr; M Ito; S D Douglas; A M Arbeter
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

7.  Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production.

Authors:  J C Fantone; W A Marasco; L J Elgas; P A Ward
Journal:  Am J Pathol       Date:  1984-04       Impact factor: 4.307

8.  Influenza A virus-induced polymorphonuclear leukocyte dysfunction.

Authors:  J S Abramson; D S Lyles; K A Heller; D A Bass
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

9.  Neutrophil-independence of the initiation of colonic injury. Comparison of results from three models of experimental colitis in the rat.

Authors:  M G Buell; M C Berin
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

10.  Effect in vitro of gamma interferon and interleukin-10 on generation of oxidizing species by human granulocytes.

Authors:  M M Chaves; A A Silvestrini; D N Silva-Teixeira; J A Nogueira-Machado
Journal:  Inflamm Res       Date:  1996-07       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.